SNHG9 and hepatocellular carcinoma: The expression of SNHG9 in patients with HCC (2.12 ± 1.68) was also significantly higher than that in the non-HCC group (1.24 ± 1.04, p < 0.001) and healthy control group (1.29 ± 0.61, p = 0.015) (Figure 2B).